PTSD Trial, Recruiting NCT06988787 Sponsor: Icahn School of Medicine at Mount Sinai Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06988787
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to give informed consent (as measured by a specific assessment tool), speak English, are female veterans, and are 18 years of age or older
  • People who screen positive for exposure to intimate partner violence (IPV) and/or military sexual trauma (MST) using standard VA screening tools
  • People who have a history of at least one brain injury, assessed using a specific screening questionnaire
  • People who have some PTSD symptoms that fall below the full diagnostic threshold, measured as a score above 33 on a standard PTSD checklist
  • People who report difficulties managing their emotions, measured as a score at least half a standard deviation above published averages on a standard scale

Who may not be able to join:

  • People who are assessed as being at high risk for suicide based on specific responses on a standard suicide risk rating scale
  • People who show signs of active psychosis, such as hearing voices or having strong false beliefs about themselves
  • People whose substance use (alcohol, smoking, or other substances) scores above 27 on a standard screening test — though these individuals may be referred to a substance use program, and continued participation in the trial may still be considered in collaboration with that program (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria Kajankova, PhD, Icahn School of Medicine at Mount Sinai

Phone: 212-241-3379

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 September 2025
Est. completion
1 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Difficulties in Emotion Regulation Scale (DERS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov